TAMPA, Fla., June 9, 2005 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC), a provider of low-cost prescription medications and diagnostic lab testing solutions, announced today that the Company has implemented a new Independent Sales Agent Program designed to rapidly deploy storefront locations throughout America with a very small capital investment. The new turnkey program will allow independent sales agents to open up a storefront location with a capital investment of as little as $2,500.
Rx Direct will provide Independent Agents with sales training and marketing assistance along with technology support including a laptop and access to Rx Processing Corp's VOIP phone network. Rx Processing is pleased to welcome Kirk Stock and Ethan Erickson as the first Independent Agents who will be opening a new "Rx Direct" storefront location in Tahlequah, OK. Mr. Stock and Mr. Erickson both possess an extensive background in the Medical Discount Plans field.
"I am very excited to join Rx Processing in opening up storefront locations that offer discounted prescription drugs and clinical diagnostic testing to those who cannot afford to pay today's overly inflated retail prices. Through my experience with medical discount, I realize the incredible potential that Rx Direct storefront has and the growth opportunities that exist within this business model," commented Kirk Stock, Independent Sales Agent for Rx Processing. "Once established, we plan to approach large groups and organizations such as Chambers of Commerce to become their primary provider of discounted prescription drugs and diagnostic testing in addition to individuals."
About Rx Processing
Rx Processing is positioned to become a market leader in providing prescription drugs, lab tests and drug tests to U.S. Citizens, corporations, unions, and members through FDA-approved patient service centers for their Lab testing and licensed pharmacies in the United States and Canada. The Company provides access to approved brand name and generic medications as well as over 1,000 diagnostic tests through storefront locations with access to 6,000 FDA-approved patient service centers for their lab testing. Rx Processing estimates that more than 40 million Americans could benefit from the Company's low cost prescription drugs, lab testing and drug screening.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.